Clinical Trial Detail

NCT ID NCT02514824
Title MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Dana-Farber Cancer Institute
Indications

Merkel cell carcinoma

Therapies

Sapanisertib

Age Groups: adult

No variant requirements are available.